Exponent, a prominent European private equity firm, has announced the final close of its fifth fund, Exponent Private Equity Partners V (Fund V), securing £900 million (over €1 billion) in commitments. This amount is 20% above its target.
Fund V garnered strong support from a diverse global investor base, including long-standing partners and new investors across North America, Europe, the Middle East, and Asia. This base comprises pension funds, endowments, sovereign wealth funds, family offices, and other leading institutional investors.
Fund V will continue Exponent’s strategy of investing in high-quality mid-market businesses, specifically established leaders that are corporate, family, or founder-owned. Exponent aims to double profits in these “primaries” through revenue-driven growth levers, a strategy it has successfully implemented with past portfolio companies.
To date, Fund V has made four investments:
1.) Chanelle Pharma: A European leader in generic and veterinary pharmaceuticals.
2.) Ethos Engineering: A specialist in sustainable data center design.
3.) Kingsbridge Healthcare Group: The largest private healthcare provider in Northern Ireland.
4.) Hippo Digital: A fast-growing technology consultancy focused on digital transformation.
Advisors: Rede Partners advised Exponent on the fundraising, with Debevoise & Plimpton serving as legal counsel.
KEY QUOTES:
“We’re grateful for the continued support of our longstanding partners and pleased to welcome a number of new investors to Fund V. The response to this fundraise reflects strong conviction in our team, track record and disciplined strategy. We look forward to building long-term relationships with our new LPs and continuing to deliver value for all our partners.”
Marius Østlie, Partner at Exponent
“We have a truly differentiated mid-market strategy which has consistently delivered value for our investors and management teams throughout economic cycles. Our ability to identify the potential for revenue driven profit growth makes us an attractive and trusted partner for corporates, families and founders. Fund V allows us to continue executing this strategy which is underpinned by discipline, sub-sector expertise and operational rigour.”
Richard Lenane, Managing Partner at Exponent
